Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar;66(3):209-216.
doi: 10.1007/s00011-016-0995-1. Epub 2016 Oct 17.

The biological function and significance of CD74 in immune diseases

Affiliations
Review

The biological function and significance of CD74 in immune diseases

Huiting Su et al. Inflamm Res. 2017 Mar.

Abstract

CD74 (MHC class II invariant chain, Ii) is a non-polymorphic type II transmembrane glycoprotein. It is clear that, in addition to be an MHC class II chaperone, CD74 has a diversity of biological functions in physiological and pathological situations. CD74 also participates in other non-MHC II protein trafficking, such as angiotensin II type I receptor. In addition, CD74 is a cell membrane high-affinity receptor for macrophage migration inhibitory factor (MIF), D-dopachrome tautomerase (D-DT/MIF-2) and bacterial proteins. CD74 also regulates T-cell and B-cell developments, dendritic cell (DC) motility, macrophage inflammation, and thymic selection. The activation of receptor complex CD74/CD44 may lead to multiple intracellular signal pathways, such as the activation of the extracellular signal regulated kinase (ERK) 1 and 2, the PI3K-Akt signal transduction cascade, NFκB, and the AMP-activated protein kinase (AMPK) pathway. CD74 plays important roles in many inflammatory diseases, such as liver fibrosis, type I diabetes, systemic lupus erythematosus, and Alzheimer disease. In this study, we will focus on the immunological functions of CD74 molecules and its roles in immune-relevant disorders.

Keywords: CD74; Inflammation; Innate immunity; MIF.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nat Med. 2000 Feb;6(2):164-70 - PubMed
    1. Stem Cell Res Ther. 2015 Apr 22;6:82 - PubMed
    1. Oncology. 2008;75(3-4):127-33 - PubMed
    1. Nature. 1991 Dec 5;354(6352):392-4 - PubMed
    1. Biochem Pharmacol. 2012 Feb 1;83(3):385-94 - PubMed

MeSH terms

Substances